Higher serum levels (>0.237) of anti-MX1 IgG autoantibody were not associated with survival and incidence of AE in IPF patients (log-rank test; p=0.159 and p=0.368, respectively; data not shown). Here, MX1 is linked to idiopathic pulmonary fibrosis.